[The occurence of prebeta1-lipoprotein fractions in diabetes mellitus]. 1977

L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić

UI MeSH Term Description Entries
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
August 1971, Rinsho byori. The Japanese journal of clinical pathology,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
December 2022, Journal of atherosclerosis and thrombosis,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
November 1989, Journal of the Medical Association of Georgia,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
January 1994, The Medical clinics of North America,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
January 1993, Clinica chimica acta; international journal of clinical chemistry,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
October 1988, Diabetologia,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
June 1987, Journal of lipid research,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
February 1992, Hospital practice (Office ed.),
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
June 1978, Atherosclerosis,
L Lepsanović, and L Lepsanović, and T Kovac, and T Ivković, and S Curić
January 2009, Biochemical and biophysical research communications,
Copied contents to your clipboard!